CD8A and neoplasm: Thus, the role of MSU-42011 in reducing FOXP3+ Tregs and increasing activated CD8+ T cells in the MPNST model is particularly intriguing (Figure 2D,E), potentially alleviating immune suppression and enhancing anti-tumor immunity.